Apical Sorting of Bovine Enteropeptidase Does Not Involve Detergent-resistant Association with Sphingolipid-Cholesterol Rafts*

Xinglong Zheng, Deshun Lu, and J. Evan SadlerDagger

From the Division of Hematology and Oncology, Department of Medicine and Barnes-Jewish Hospital, Howard Hughes Medical Institute, Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Enteropeptidase is a heterodimeric type II membrane protein of the brush border of duodenal enterocytes. In this location, enteropeptidase cleaves and activates trypsinogen, thereby initiating the activation of other intestinal digestive enzymes. Recombinant bovine enteropeptidase was sorted directly to the apical surface of polarized Madin-Darby canine kidney cells. Replacement of the cytoplasmic and signal anchor domains with a cleavable signal peptide (mutant proenteropeptidase lacking the amino-terminal signal anchor domain (dSA-BEK)) caused apical secretion. The additional amino-terminal deletion of a mucin-like domain (HL-BEK) resulted in secretion both apically and basolaterally. Further deletion of the noncatalytic heavy chain (L-BEK) resulted in apical secretion. Thus enteropeptidase appears to have at least three distinct sorting signals as follows: the light chain (L-BEK) directs apical sorting, addition of most of the heavy chain (HL-BEK) inhibits apical sorting, and addition of the mucin-like domain (dSA-BEK) restores apical sorting. Inhibition of N-linked glycosylation with tunicamycin or disruption of microtubules with colchicine caused L-BEK to be secreted equally into apical and basolateral compartments, whereas brefeldin A caused basolateral secretion of L-BEK. Full-length BEK was not found in detergent-resistant raft domains of Madin-Darby canine kidney cells or baby hamster kidney cells. These results suggest apical sorting of enteropeptidase depends on N-linked glycosylation of the serine protease domain and an amino-terminal segment that includes an O-glycosylated mucin-like domain and three potential N-glycosylation sites. In contrast to many apically targeted proteins, enteropeptidase does not form detergent-resistant associations with sphingolipid-cholesterol rafts.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Enteropeptidase (enterokinase) is a protease of the duodenal brush border that cleaves and activates trypsinogen. The resultant trypsin then activates other pancreatic digestive zymogens within the lumen of the gut. Deficiency of enteropeptidase causes intestinal malabsorption (1, 2), and intrusion of enteropeptidase into the pancreas may contribute to hemorrhagic pancreatitis (3, 4). Therefore, the localization of enteropeptidase is important to normal digestive physiology.

Enteropeptidase consists of a disulfide-linked heterodimer with a heavy chain of 82-140 kDa and a light chain of 35-62 kDa. Both chains of mammalian enteropeptidases contain 30-50% carbohydrate, and this extensive glycosylation may contribute to the apparent variation in polypeptide masses (reviewed in Ref. 5). Amino acid sequences deduced by cDNA cloning of bovine (6, 7), porcine (8), human (9), mouse (10), and rat enteropeptidase (11) indicate that active two-chain enteropeptidase is derived from a single-chain precursor. The amino-terminal heavy chain contains domains that are homologous to sequences of O-glycosylated epithelial mucins, the low density lipoprotein receptor, complement components C1r and C1s, the macrophage scavenger receptor, and a recently described MAM motif. The carboxyl-terminal light chain is homologous to the trypsin-like serine proteases (reviewed in Ref. 5). Studies of recombinant bovine enteropeptidase demonstrate that membrane association is mediated by a signal anchor sequence near the amino terminus (12).

The structures on enteropeptidase that direct it to apical membranes have not been characterized. Basolateral targeting generally is mediated by discrete amino acid sequence motifs in the cytoplasmic domains of transmembrane proteins, whereas the nature of apical targeting signals remains controversial. Apical targeting appears to depend on distributed features of protein ectodomains or transmembrane domains, and there may be several apical targeting mechanisms (13). For some proteins, apical targeting requires N-linked oligosaccharides (14, 15), or juxtamembrane segments with clustered O-linked oligosaccharides (16), or interactions of transmembrane domains (17) or glycosylphosphatidylinositol anchors (18, 19) with the lipid bilayer. Apical sorting determinants may function, in part, by promoting association with sphingolipid-cholesterol rafts that deliver proteins to the apical cell surface (20). However, some apical proteins appear not to associate with rafts and lack any of the currently recognized apical sorting signals (e.g. Ref. 21), and proteins may be sorted differently in different cell types (13). Therefore, the mechanism of apical protein targeting remains poorly understood.

We have employed Madin-Darby canine kidney (MDCK)1 cells, a well characterized system for the study of protein sorting (13, 22), to investigate the targeting of enteropeptidase. The results indicate that signals involved in apical delivery reside in the catalytic domain and in an amino-terminal segment that includes the mucin-like domain. Apical delivery of this type II transmembrane protein requires intact post-Golgi transport vesicles and depends on N-linked glycosylation. Unlike many other apically targeted proteins, delivery of enteropeptidase appears not to involve detergent-resistant association with sphingolipid-cholesterol rafts.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Construction of Plasmids-- Plasmid pBEK, containing the full-length cDNA sequence of bovine enteropeptidase, was assembled in vector pBluescript II KS+ (Stratagene) from cDNA clones isolated previously (7). The cDNA insert of pBEK was cloned into the SmaI site of plasmid pNUT (23) to produce expression plasmid pNUTBEK. Plasmids pNUTHL, pNUTL, pBlue-HL, and pBlue-L were described previously (12). In pNUTHL and pBlue-HL, the sequence encoding amino acids 1-197 was replaced by a signal peptide cassette consisting of the cleavable signal peptide of prothrombin, a His6 tag, thrombin cleavage site, and T7 epitope tag. In plasmid pNUTL and pBlue-L, the same signal peptide cassette replaced the sequence encoding amino acids 1-783. Additional plasmids derived from pBEK were constructed using oligonucleotide site-directed mutagenesis as described previously (12). In plasmid pdSA, the sequence encoding the signal-anchor domain (residues 1-49) was replaced by the prothrombin signal peptide cassette from plasmid pNUTHL.

To add the epitope tag DYKDDDDK to the carboxyl terminus of full-length recombinant enteropeptidase, the DNA sequence 5'-gac tac aag gac gac gat gac aag tag-3' was inserted before the stop codon of plasmid pBEK, generating the plasmid pBEKflag. Plasmid pdSALflag was derived from pdSA by inserting the same oligonucleotide sequence before the codon for residue 787, thereby deleting the light chain and appending the DYKDDDDK tag. The cDNA inserts of pBEK, pBEKflag, pdSA, pdSALflag pBlue-HL, and pBlue-L were excised from the vectors with NotI and ApaI or NotI and HindIII and cloned into vectors pcDNA3, pcDNA3.1, or pcDNAI (Invitrogen) to yield plasmids pcDNA3-BEK, pcDNA3-BEKflag, pcDNA3.1-dSA, pcDNA3.1-dSAdLflag, pcDNAI-HL, and pcDNAI-L, respectively.

Transfections-- Baby hamster kidney (BHK) cells were grown in six-well plates and transfected with 5 µg of plasmid pNUT-BEK, pNUT-HL, and pNUT-L, and 30 µg of Lipofectin (Life Technologies, Inc.) in serum-free Dulbecco's modified Eagle's medium (DMEM). After 5 h fetal bovine serum was added to 10%. After an additional 18 h, cultures were split 1:10 for selection in 0.5 mg/ml methotrexate for 10 days. Madin-Darby canine kidney (MDCK-II) cells (ATCC) were transfected with 5 µg of plasmid pcDNA3-BEK, pcDNA3-BEKflag, pcDNA3.1-dSA, pcDNA3.1-dSAdLflag, pcDNAI-HL, or pcDNAI-L and PerFect lipids (pfx-2) (Invitrogen) according to the manufacturer's recommendations, and clones were selected with 0.5 mg/ml geneticin (G418) (Life Technologies, Inc.).

Polyclonal Antibodies-- The cDNA sequence encoding the light chain of bovine enteropeptidase (amino acids 784-1035) was cloned into the XhoI site of plasmid pET-28a(+) (Novagen) to yield plasmid pET-L. Epicurean coli BL21 (DE3) (Stratagene, La Jolla, CA) transformed with plasmid pET-L were grown in LB broth containing ampicillin, and protein expression was induced with 1 mM isopropyl-1-thio-beta -D-galactopyranoside, and cells were lysed with 40 mM MOPS, pH 7.5, 100 mM NaCl, 1% Triton X-100, 6 M urea, 300 mM imidazole, 10 mM dithiothreitol, and 100 µg/ml soybean trypsin inhibitor. After centrifugation, the supernatant solution was dialyzed against binding buffer (20 mM MOPS, pH 7.9, 50 mM NaCl, 0.5% Triton X-100) containing decreasing concentrations of urea (4 M to zero). Recombinant enteropeptidase light chain was purified by chromatography on Ni2+-nitrilotriacetic acid-agarose (12). Polyclonal antibodies to the purified light chain were prepared in rabbits by standard methods (24). Specific immune IgG against denatured light chain (anti-L) was purified by sequential affinity chromatography on protein A-agarose and on enteropeptidase light chain immobilized on Affi-Gel 10 (Bio-Rad).

Antibodies against native enteropeptidase light chain were prepared similarly. The cDNA insert encoding amino acids 785-1035 of pBlue-L was cloned into baculovirus expression vector pVL1392 (PharMingen, San Diego, CA). Plasmid pVL1392-L was co-transfected into Sf9 cells (Life Technologies, Inc.) with BaculoGold DNA (PharMingen, San Diego, CA) to generate recombinant virus. Enteropeptidase light chain was expressed by infection of High Five cells (Life Technologies, Inc.) and purified by affinity chromatography on soybean trypsin inhibitor-agarose (Sigma).2 Polyclonal antibody against the purified active L-BEK was raised in rabbits (TANA Laboratories, Houston, TX), and the immune serum was designated anti-Lv.

Preparation of Cell Lysate and Immunoblotting-- Stably transfected BHK or MDCK II cell lines were maintained in DMEM containing 10% fetal bovine serum. Cells were lysed directly in the plate at room temperature with sodium phosphate, pH 7.4, 150 mM NaCl (PBS) containing 1% Triton X-100, 0.5 mM phenylmethylsulfonyl fluoride (PMSF), and 3 µM aprotinin (1 ml/107 cells). After centrifugation at 15,000 rpm for 15 min in a microcentrifuge, the supernatants were stored at -70 °C. For Western blotting, proteins were fractionated in 4-15% gradient polyacrylamide electrophoresis gels (Bio-Rad) and transferred by electroblotting onto supported nitrocellulose membranes (pore size 0.4 µm,, Bio-Rad). Membranes were blocked with 3% non-fat milk in 20 mM Tris-HCl, pH 7.5, 150 mM NaCl (TBS) containing 0.05% Tween 20 (TBST) at room temperature for 30 min. The blocked membrane was incubated with 1.5 µg/ml affinity purified anti-L-IgG or anti-Lv-antiserum (1:4000) diluted in TBST containing 1.5% non-fat milk at 4 °C overnight. Membranes were washed four times with TBST, once with TBS, and incubated with peroxidase-conjugated affinity purified swine anti-rabbit IgG (Dako Corp., Carpinteria, CA) 0.12 µg/ml in TBST containing 1.5% milk at room temperature for 1-2 h. Bound second antibody was detected with the chemiluminescent ECL detection system (Amersham Pharmacia Biotech).

Glycosidase Digestions-- To analyze the N-glycosylation of proenteropeptidase, 10 µl of BHK cell lysate or conditioned medium was incubated at 100 °C for 5 min in 30 µl total volume of 20 mM sodium phosphate, pH 7.5, 50 mM EDTA-Na, 0.4% SDS, 4% beta -mercaptoethanol, and 0.02% sodium azide. Denatured and reduced proteins (30 µl) were then digested without (control) or with 0.5 units of peptide-N-glycosidase F (Oxford Glycosciences, Bedford, MA) or 1 milliunit of endoglycosidase H (Boehringer Mannheim) in a total volume of 30 µl at 37 °C for 16 h. Samples (10 µl) of these digested materials were analyzed by Western blotting.

For digestion with neuraminidase and O-glycanase, BHK cells expressing BEK were pulse-labeled with 200 µCi/ml Tran35S-label (>1000 Ci/mmol, containing 75% [35S]methionine, 15% [35S]cysteine, ICN Pharmaceuticals) at 37 °C for 30 min and chased for 60 min with complete DMEM containing an excess of unlabeled methionine (15 µg/ml) and cysteine (50 µg/ml). Cell lysates were prepared as described above, pre-cleared for 60 min with protein A-Sepharose 4B (50 µl/ml sample), and incubated with anti-Lv (5-10 µl/ml lysate) and 5 mg/ml bovine serum albumin at 4 °C overnight. After addition of protein A-Sepharose 4B (50 µl), samples were incubated for 60 min at room temperature. The protein A-Sepharose beads were washed four times with 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% Triton X-100, 0.1% SDS, and once with 20 mM Tris-HCl, 150 mM NaCl, pH 7.4. Antigen-antibody complexes were eluted by boiling at 100 °C for 10 min with 100 µl of 20 mM Tris-HCl, pH 7.4, 0.5% SDS. Samples of eluate (20 µl) or 20 ng of purified HL-BEK (12) were digested without or with 0.5 units of PNGase F, 20 milliunits of neuraminidase (Boehringer Mannheim) or 20 milliunits of neuraminidase plus 2 milliunits of O-glycanase (Genzyme Diagnostic, Cambridge, MA) in 20 mM sodium cacodylate, pH 6.5, 10 mM calcium acetate, 0.2% SDS, and 2% Nonidet P-40 at 37 °C for 20 h. The products were separated electrophoretically by 4-20% gradient SDS-PAGE; radiolabeled BEK and unlabeled HL-BEK were detected by autoradiography and silver staining, respectively.

Cell-surface Biotinylation of BEK and HL-BEK Expressed in BHK Cells-- BHK cell lines were washed three times with ice-cold PBS, incubated with 1.5 mg/ml NHS-SS-biotin (Pierce) at 4 °C for 30 min, and reaction was stopped with 50 mM glycine in PBS. Cells were lysed in 1 ml of PBS containing 1% Triton X-100, 0.5 mM PMSF, and 3 µM aprotinin. Surface biotin-labeled proteins were precipitated with streptavidin-agarose at room temperature for 2 h. After washing four times with PBS containing 0.1% Triton X-100 and 0.1% SDS, the biotin-streptavidin-agarose complexes were eluted from beads by heating at 100 °C for 5 min with 30 µl of Laemmli sample buffer (Bio-Rad) containing 1% beta -mercaptoethanol. The cell lysate, flow-through, and eluate fractions from streptavidin-agarose were analyzed by SDS-polyacrylamide gel electrophoresis and Western blotting.

Trypsin Accessibility of BEK and HL-BEK Expressed in BHK Cells-- Transfected BHK cell lines in six-well plates were washed with PBS and treated without (control) or with 5 µg/ml trypsin-L-1-tosylamido-2-phenylethyl chloromethyl ketone (Worthington) in PBS at room temperature for 10 min. Residual trypsin was inactivated by addition of a 2-fold excess of soybean trypsin inhibitor. Cells were pelleted, washed with PBS, and lysed with PBS containing 0.5% Triton X-100, 0.1% SDS, 100 µg/ml PMSF, 24 µg/ml aprotinin, 1.5 µg/ml soybean trypsin inhibitor. Cell lysate was centrifuged at 15,000 rpm in a microcentrifuge, and the supernatant was collected for SDS-PAGE and Western blotting.

Immunofluorescence and Confocal Microscopy-- Stably transfected MDCK II cells were grown on clear Costar Transwell filters (pore size 0.4 µm) until a tight monolayer was formed as shown by the transepithelial resistance. The filters were washed with PBS and fixed at 4 °C for 15 min in PBS containing 1.5% paraformaldehyde (25) or ethanol:acetic acid (9:1). Cells were washed sequentially with PBS followed by PBS containing 0.5% Triton X-100, 1% BSA, and 1% goat serum and then incubated in PBS containing 20 µg/ml rabbit anti-Lv serum (1:100) or anti-caveolin IgG (1:500) (Transduction Laboratories, Lexington, KY), 1% BSA, and 1% goat serum at 4 °C overnight. Cells were washed three times with PBS containing 0.05% Tween 20 and once with PBS and then incubated with Cy3-labeled goat anti-rabbit antibody (15 µg/ml diluted with TBS containing 1.5% non-immune goat serum) (Jackson ImmunoResearch, West Grove, PA) at room temperature for 60 min. After washing, the filters were cut out and mounted on slides with glycerol mounting medium (Sigma) and examined with a confocal laser-scanning microscope (Zeiss Axioplan/Bio-Rad MRC1024).

Analysis of Enteropeptidase Polarity on MDCK Cells-- To detect membrane-bound enteropeptidase, stably transfected MDCK cells were grown on six-well Costar Transwell filters (pore size 0.4 µm) until a tight monolayer was formed as shown by the transepithelial resistance. Cells were pulse-labeled with 150-200 µCi/ml Tran35S-label at 37 °C for 30 min and chased for 30 min with complete DMEM containing 150 µg/ml unlabeled methionine. Either the apical or basolateral cell surface was incubated with 1.5 mg/ml sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithiopropionate (NHS-SS-biotin, Pierce) at 4 °C for 30 min, and the reaction was stopped with 50 mM glycine in PBS (10 ml per 100-mm dish), and cell lysates were prepared as described above. Enteropeptidase was immunoprecipitated with anti-Lv (10-30 µg/ml sample) and protein A-Sepharose 4B (50 µl). Antigen-antibody complexes were eluted by boiling at 100 °C for 10 min with 100 µl of 20 mM Tris-HCl, pH 7.4, containing 0.5% SDS. The eluate was diluted to 500 µl with 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, and biotin-labeled proteins were precipitated with streptavidin-agarose as described above. Proteins were eluted from streptavidin-agarose with Laemmli sample buffer containing 1% beta -mercaptoethanol, separated on 4-15% gradient mini-ready gels (Bio-Rad), fixed with 40% methanol, 10% acetic acid, treated with Amplify fluorographic reagent (Amersham Pharmacia Biotech) for 30 min, dried, and exposed to XAR5 film (Eastman Kodak Co.) at -70 °C. Alternatively, to detect secreted forms of enteropeptidase, conditioned medium from either apical or basolateral surfaces was collected, immunoprecipitated with anti-Ly, and fractionated by SDS-PAGE. The enteropeptidase then was visualized by either autoradiography (if labeled with Tran35S-label) or Western blotting.

Effects of Tunicamycin, Brefeldin A, and Colchicine on Targeting of Enteropeptidase-- MDCK II cells transfected with pcDNAI-L were grown on Costar Transwell filters until formation of a tight monolayer as determined by transepithelial resistance measurements. Cells were then treated without or with 2 µg/ml tunicamycin or 10 µg/ml brefeldin A in serum-free DMEM for 24 h. The cell viability and integrity of the monolayer were confirmed after treatment by measuring the transepithelial resistance. Conditioned media were collected from either apical or basolateral surfaces and concentrated 10-fold by ultrafiltration (Centriprep-10). Samples (20 µl) of concentrated media were analyzed by SDS-polyacrylamide gel electrophoresis and Western blotting as described above. The amount of L-BEK secreted from either surface was quantitated with NIH Image version 1.61 (26).

Triton X-100 Extraction-- Detergent extractability of enteropeptidase was determined according to Brown and Rose (27). Confluent cell monolayers in 10-cm dishes were labeled with 200 µCi/ml Tran35S-label in serum-free DMEM without methionine for 30 min at 37 °C and chased at 37 or 20 °C with DMEM, F-12 HEPES medium containing an excess of unlabeled methionine (15 µg/ml) and cysteine (50 µg/ml). The cells were lysed with 1 ml of extraction buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.5 mM PMSF, and 3 µM aprotinin) for 10 min on ice. Lysates were centrifuged for 5 min in a microcentrifuge at 15,000 rpm at 4 °C. The supernatant (Triton X-100 soluble fraction) was removed. The pellet (Triton X-100 insoluble fraction) was dissolved in 100 µl of 50 mM Tris-HCl, pH 8.0, 5 mM EDTA, and 1% SDS; DNA was sheared by passage through a 22-gauge needle, and the solution was diluted by addition of 900 µl of extraction buffer. Enteropeptidase was immunoprecipitated from soluble and insoluble fractions with anti-Lv (5 µl/ml) for analysis by SDS-PAGE and autoradiography as described above.

Isolation of Low Density Membrane Domains-- Detergent-insoluble glycosphingolipid-enriched raft domains were prepared by a modification of the Triton X-100 procedure of Pike and Casey (28). Confluent cells in 100-mm dishes were rinsed twice with ice-cold PBS and scraped into 1 ml of lysis buffer containing 25 mM MES, pH 6.5, 150 mM NaCl, 1% Triton X-100, 10 mM benzamidine, 1 mM phenylmethylsulfonyl fluoride, and 0.3 mM aprotinin. Lysates were incubated for 20 min on ice with intermittent gentle agitation and then mixed with an equal volume of 80% sucrose in MBS (25 mM MES, pH 6.5, 150 mM NaCl). Six ml of 30% sucrose in MBS followed by 4 ml of 5% sucrose in MBS were layered on top of each sample. The gradients were centrifuged at 4 °C for 23 h at 175,000 × g (39,000 rpm, Beckman SW40 rotor). Fractions of 1.2 ml were collected, and the small insoluble pellet was resuspended in 600 µl of lysis buffer by homogenization (25,000 rpm, 1 min) with a Brinkmann homogenizer (Kinematica AG, Switzerland). Proteins in the fractions were precipitated with 10% trichloroacetic acid on ice for 30 min, and pellets were resuspended in 100 µl of 0.2 N NaOH. Samples (20 µl) of trichloroacetic acid-concentrated fractions were analyzed by SDS-PAGE and immunoblotting with either anti-Lv (1:4,000) or anti-caveolin IgG (1:10,000) (Transduction Laboratories, Lexington, KY).

Antibody-induced Patching-- BHK cells expressing BEK were cultured in 150-mm dishes to 90% confluency in DMEM, 10% fetal bovine serum and washed twice with 10 ml of ice-cold PBS. Cells were incubated without (control) or with anti-Lv (preabsorbed with non-transfected BHK cell lysate coupled on Affi-Gel 10) at a dilution of 1:1000 in serum-free DMEM, 0.1% BSA at 12 °C for 60 min. After washing three times with 10 ml of ice-cold PBS, cells were further incubated with goat anti-rabbit IgG (1:1000) at 12 °C for 60 min. Cells were scraped into 25 mM MES, pH 6.5, 150 mM NaCl, 1% Triton X-100, 10 mM benzamidine, 1 mM phenylmethylsulfonyl fluoride, and 0.3 mM aprotinin. Sucrose gradient centrifugation and Western blotting were performed as described above. For immunofluorescence, cells grown on slide chambers were either fixed with acetic acid:ethanol (1:9) on ice for 10 min and incubated with anti-Lv (1:1000) and Cy3-conjugated anti-rabbit IgG (1:50), or first cross-linked with primary and secondary antibodies at 12 °C for 60 min before fixing with acetic acid ethanol (1:9) on ice for 10 min. After washing with PBS, cells were mounted with 30% glycerol in 20 mM Tris-HCl, pH 7.4, and photographed with a Zeiss Axiophot microscope.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Enteropeptidase Is Expressed as a Single-chain Zymogen with Extensive N-Linked and O-Linked Glycosylation-- BHK cells expressed two major species of cell-associated full-length proenteropeptidase (BEK) with molecular masses of 180 and 150 kDa (Fig. 1A, lane 1). These apparent sizes are similar to those for secreted and intracellular forms, respectively, of proenteropeptidase lacking the transmembrane and mucin-like domains, HL-BEK (Fig. 1A, lanes 4 and 7), as reported previously (12). Digestion of BEK (Fig. 1A, lane 3) or HL-BEK (Fig. 1A, lanes 6 and 9) with protein N-glycosidase F (PNGase) reduced the apparent mass of all species to approx 120 kDa, indicating that much of the difference between the observed sizes and the predicted polypeptide mass of 110 kDa is due to N-linked glycosylation. The 150-kDa species were sensitive to both endoglycosidase H (endo H) and PNGase, indicating that the N-linked oligosaccharides consist of high mannose structures. The 180-kDa species were resistant to endo H (Fig. 1A, lane 2), indicating the presence of complex-type oligosaccharides. Therefore, the 150-kDa species appears to be localized in the endoplasmic reticulum and are converted to 180-kDa species by oligosaccharide processing in the Golgi. Deletion of the remainder of the heavy chain yielded a secreted 45-50-kDa protein, L-BEK, consisting of the enteropeptidase catalytic domain. As expected for a secreted glycoprotein, the N-linked oligosaccharides of L-BEK were resistant to endo H (Fig. 1A, lane 11) but sensitive to PNGase (Fig. 1A, lane 12).


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 1.   Glycosidase digestion of wild-type and mutant recombinant enteropeptidases expressed in BHK cells. A, to evaluate N-linked glycosylation patterns, cell lysates or conditioned media were prepared from stably transfected BHK cells expressing distinct forms of enteropeptidase. Samples (10 µl) were digested without (-) or with (+) peptide N-glycosidase F (PNGase) or endoglycosidase H (Endo H) and analyzed by gel electrophoresis and Western blotting as described under "Experimental Procedures." B, to evaluate O-linked glycosylation patterns, BHK cells expressing full-length enteropeptidase (BEK) were pulse-labeled with Tran35S-label, and cell lysates or conditioned media were prepared and immunoprecipitated with anti-enteropeptidase antibody. Samples of immunoprecipitates or purified HL-BEK were digested without (-) or with (+) PNGase F, neuraminidase (Neur), or neuraminidase plus O-glycanase. After gel electrophoresis as described under "Experimental Procedures," BEK was visualized by autoradiography and HL-BEK was visualized by silver staining.

Digestion of proenteropeptidase (BEK) with neuraminidase and O-glycanase also decreased its apparent mass, in this case by approx 14 kDa (Fig. 1B). Deletion of the amino-terminal 197 residues in HL-BEK (Fig. 1B) prevented the change in mobility associated with O-glycanase digestion, suggesting a major O-glycosylated region lies between residues 48 and 197 in the exoplasmic part of the heavy chain. A possible site for this O-linked glycosylation is the mucin-like domain between residues 166 and 192.

None of these variants of enteropeptidase had detectable enzymatic activity prior to cleavage and activation by trypsin, as reported previously (12), indicating that all are synthesized predominantly as single chain zymogens.

Enteropeptidase Is Localized to the Apical Surface of Polarized Cells-- Biotin surface labeling of transfected BHK cell lines showed that virtually all of the 180-kDa form of BEK was exposed on the plasma membrane, whereas the 150-kDa species of both BEK and HL-BEK were mainly intracellular (Fig. 2A). Surface localization of 180-kDa BEK also was demonstrated by digestion with trypsin (Fig. 2B). The 180-kDa form of BEK was cleaved into catalytically active two-chain enteropeptidase, whereas the intracellular 150-kDa forms of BEK and HL-BEK were inaccessible to trypsin. When expressed in polarized MDCK cells, BEK was localized to the apical surface as shown by immunofluorescence staining and confocal laser-scanning microscopy (Fig. 3), and by selective biotinylation of apical and basolateral membrane proteins (Fig. 4). As observed for several other apical membrane proteins in MDCK cells (22, 29), pulse labeling of BEK showed that it was delivered directly to the apical surface within 30 min of chase (data not shown).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 2.   Cell-surface exposure of BEK and HL-BEK in BHK cell lines. A, accessibility to surface biotinylation. BHK cell lines expressing BEK or HL-BEK were labeled with 1.5 mg/ml NHS-SS-biotin, and cell lysates were subjected to precipitation with streptavidin-agarose. Samples of total cell lysate (T), streptavidin-agarose flow-through (F), and eluate (S) were analyzed by gel electrophoresis and Western blotting as described under "Experimental Procedures." B, accessibility to extracellular trypsin. BHK cell lines expressing BEK or HL-BEK were treated without (-) or with (+) trypsin, and cell lysates were prepared, and samples were analyzed by gel electrophoresis and Western blotting as described under "Experimental Procedures."


View larger version (75K):
[in this window]
[in a new window]
 
Fig. 3.   Immunofluorescence and confocal microscopy of proenteropeptidase (BEK) in transfected MDCK II cells. Transfected MDCK II cells expressing full-length enteropeptidase (BEK) were grown on Costar clear Transwell filters to form a tight monolayer, fixed in 1.5% paraformaldehyde (A and a) or ethanol:acetic acid (9:1) (B and b), and incubated with either anti-Lv (A) or anti-caveolin IgG (B) and Cy3-conjugated goat anti-rabbit IgG, and examined by confocal laser-scanning microscopy as described under "Experimental Procedures." A and B show x-y scans parallel to the plane of the filter near the apex of the cells. Enteropeptidase exhibits an apical staining pattern (A), whereas caveolin is localized laterally (B). Some cells in this mixed cell line do not express enteropeptidase, and this accounts for the patchy staining in A. The insets (a and b) show scans along the x-z dimension and demonstrate the apical localization of enteropeptidase (a) and basolateral localization of caveolin (b).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 4.   Domains required for apical sorting of enteropeptidase. Stably transfected MDCK II cell lines expressing variants of enteropeptidase were grown on Costar Transwell units. For detection of membrane-associated enteropeptidase, cells were labeled from either the apical (Ap) or basolateral (Bl) side with NHS-SS-biotin. Biotinylated proteins in cell lysates were isolated with streptavidin-agarose for SDS-PAGE and Western blotting with anti-L antibody (BEK) or anti-flag antibody (BEK.Flag). For analysis of secreted forms of enteropeptidase (dSA, dSAdL.Flag, HL, and L), conditioned media were collected from either the apical or basolateral side surface of MDCK cells. Cell lines expressing dSA or dSAdL.Flag were biosynthetically labeled with Tran35S-label, and conditioned medium was analyzed by immunoprecipitation and autoradiography. Conditioned medium from cells expressing BEK, BEK.Flag, HL, or L was analyzed by Western blotting with anti-Lv. The amount of apically sorted enteropeptidase was quantitated from two independent experiments and expressed as a percentage of the total.

Multiple Signals Contribute to Apical Sorting of Enteropeptidase-- Targeting signals in enteropeptidase were localized further by deletion mutagenesis (Fig. 4). Constructs were prepared that lacked the transmembrane domain (dSA-BEK), the mucin-like domain (HL-BEK), the entire heavy chain (L-BEK), or the light chain (dSAL-BEK). Because the available antibodies were specific for the enteropeptidase light chain, a short peptide epitope (DYKDDDDK) was attached to the carboxyl terminus of construct dSAL-BEK to facilitate immunoprecipitation and Western blotting. Adding this epitope to full-length BEK in construct BEKflag did not impair expression or apical targeting (Fig. 4), suggesting that the tag would not perturb biosynthesis of other constructs. Cells were grown as tight monolayers on porous filters in Transwell units. The targeting of membrane-associated BEK and BEKflag was assessed by surface biotinylation. The targeting of secreted proteins dSA-BEK, dSAL-BEK, HL-BEK, and L-BEK was assessed by analysis of culture medium exposed selectively to apical and basolateral surfaces.

Replacement of the signal anchor domain with a cleavable signal peptide resulted in the secretion of construct dSA-BEK from the apical cell surface, whereas amino-terminal deletion including the mucin-like domain resulted in both apical and basolateral secretion of construct HL-BEK (Fig. 4). Therefore, an apical targeting determinant appears to reside near the amino terminus of enteropeptidase in a segment (residues 48-197) that contains a mucin-like domain and is O-glycosylated (Fig. 1B). Deletion of the entire heavy chain again resulted in apical secretion of construct L-BEK (Fig. 4), suggesting that the heavy chain can inhibit the function of a second apical targeting determinant that resides in the enteropeptidase light chain. This light chain sorting determinant also is not required for correct targeting because deletion of the light chain did not impair apical localization of construct dSAL-BEK (Fig. 4). Thus, enteropeptidase appears to have at least three distinct targeting signals as follows: the enteropeptidase light chain (L-BEK) directs apical secretion, addition of the heavy chain (HL-BEK) inhibits apical sorting and causes delivery to both apical and basolateral surfaces, and addition of an amino-terminal segment containing the mucin-like domain (dSA-BEK) restores apical sorting.

Effect of Tunicamycin, Colchicine, and Brefeldin A on L-BEK Secretion in MDCK Cells-- Some secretory proteins (14) and transmembrane proteins (15) appear to employ N-glycans as apical sorting signals, and inhibition of N-glycosylation often causes delivery to both apical and basolateral surfaces. The serine protease domain of bovine enteropeptidase contains three potential N-linked glycosylation sites (7), and to assess the role of N-glycans in the sorting of L-BEK, transfected MDCK cells were treated with tunicamycin (Fig. 5). Glycosylation was inhibited effectively as shown by the approx 15-kDa decrease in the apparent mass of L-BEK, and secretion was reduced significantly by retention within the endoplasmic reticulum. However, in contrast to the apical secretion of glycosylated L-BEK, the under-glycosylated protein was secreted randomly from both basolateral and apical surfaces (Fig. 5). A small residual quantity of fully glycosylated L-BEK was secreted apically, indicating that the sorting pathway remained capable of correctly delivering apical glycoproteins after exposure of cells to tunicamycin. Thus, the apical targeting signal of L-BEK appears to include N-glycans. Similar experiments could not be performed for membrane-bound BEK or secreted variants containing the heavy chain because inhibition of glycosylation with tunicamycin caused complete intracellular retention (data not shown).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 5.   Effects of tunicamycin, brefeldin A, and colchicine on sorting of the secreted enteropeptidase light chain. Tight monolayers of MDCK II cells expressing enteropeptidase light chain (L) were grown on Costar Transwell filters and treated with 2 µg/ml tunicamycin (Tun), 10 µg/ml brefeldin A (BFA), or 12 µg/ml colchicine (Colch) in serum-free medium for 18-24 h. Control cells (Con) were incubated similarly. A, conditioned medium was collected from the apical (Ap) or basolateral (Bl) surface and analyzed by SDS-PAGE and Western blotting. gp, glycosylated; dgp, deglycosylated. B, the amount of apically secreted L-BEK was quantitated from three independent experiments and expressed as a percentage of the total. C, the transepithelial resistance was not significantly affected by the various treatments.

Apical targeting of some secreted and membrane proteins in MDCK cells is selectively impaired by agents that depolymerize microtubules (30, 31) or by treatment with brefeldin A (32, 33). The behavior of L-BEK is consistent with these findings. Treatment of MDCK cells with colchicine resulted in the delivery of L-BEK randomly to apical and basolateral surfaces (Fig. 5). Treatment with brefeldin A reversed the polarity of L-BEK secretion so that nearly 75% was recovered from the basolateral compartment (Fig. 5). Transmembrane conductivity measurements confirmed that neither colchicine nor brefeldin A altered the integrity of the polarized cell monolayer (Fig. 5C). Apical secretion of L-BEK therefore depends on an intact microtubular network and on brefeldin A-sensitive vesicular transport, probably at a site between the trans-Golgi network and the apical plasma membrane (33).

Enteropeptidase Is Not Associated with Detergent-resistant Glycosphingolipid-Cholesterol Rafts-- Many apically directed membrane proteins can be recovered in specialized membrane domains that are rich in glycosphingolipids and cholesterol and that are relatively insoluble in Triton X-100, termed "rafts" (20). However, full-length enteropeptidase expressed in either BHK or MDCK cells was completely solubilized by brief treatment of the cells with Triton X-100 at 4 °C (Fig. 6A). Also, when rafts were prepared by sucrose density gradient centrifugation of Triton X-100 extracts, no enteropeptidase (BEK) was recovered in the low density fractions 4 and 5 that contain caveolin, a marker for rafts; instead BEK was found in fractions that contain soluble proteins (Fig. 7).


View larger version (51K):
[in this window]
[in a new window]
 
Fig. 6.   Detergent solubility of enteropeptidase in MDCK and BHK cells. A, cells expressing full-length enteropeptidase (BEK) were labeled with Tran35S-label for 30 min, chased at 37 °C for 30 min, and extracted on ice with buffer containing 1% Triton X-100. Detergent- soluble (S) and detergent-insoluble fractions (I) of cell lysates were separated by centrifugation and analyzed by immunoprecipitation, SDS-PAGE, and autoradiography as described under "Experimental Procedures." B, BHK cells expressing BEK were labeled with Tran35S-label and chased at 37 or 20 °C. At the indicated times, samples were extracted with Triton X-100, immunoprecipitated, and incubated with (+) or without (-) endo H. Reactions were analyzed by SDS-PAGE and autoradiography. The mobilities of glycosylated (gp) and deglycosylated (dgp) enteropeptidase are indicated. Conditions in C are the same as in B, except that the time of chase was extended to 300 min.


View larger version (62K):
[in this window]
[in a new window]
 
Fig. 7.   Sucrose density gradient analysis of the raft association of enteropeptidase in MDCK and BHK cells. Cells expressing BEK were grown in 150-mm dishes and extracted on ice in MES buffer, pH 6.5, containing 1% Triton X-100. Lysates were subjected to sucrose density gradient centrifugation, and fractions were analyzed for enteropeptidase (EK) or caveolin (Cav) by Western blotting as described under "Experimental Procedures."

Some apical transmembrane proteins (34) and glycosylphosphatidylinositol-anchored proteins (27) that are incorporated into rafts during biosynthesis appear to acquire resistance to Triton X-100 extraction after departure from the endoplasmic reticulum. Certain intestinal brush border enzymes begin to associate with detergent-resistant rafts while still in their transient high mannose-glycosylated forms (35). To evaluate the possibility that enteropeptidase could associate with rafts transiently en route to the cell surface, pulse-chase analyses were performed with BHK cells expressing BEK. When cells labeled with radioactive methionine and cysteine were chased at 37 °C (Fig. 6B), enteropeptidase with endo H-sensitive oligosaccharides was detected in the detergent-soluble fractions from the earliest time point and decreased during the following 2 h. Endo H-resistant enteropeptidase appeared after 1 h of chase, consistent with oligosaccharide processing in the Golgi. At no time of chase was enteropeptidase found to be resistant to detergent extraction.

Growth of cells at 20 °C blocks the intracellular transport of certain proteins, often resulting in their accumulation within the trans-Golgi of MDCK cells (36) or BHK cells (37). To determine whether this block would cause the intracellular accumulation of a transient raft-associated enteropeptidase species, BHK cells expressing BEK were pulse-labeled with radioactive methionine and cysteine and chased at 20 °C (Fig. 6, B and C). Under these conditions enteropeptidase contained endo H-sensitive oligosaccharides at all times of chase through 5 h, indicating that transport was blocked at or before the mid-Golgi, possibly in the endoplasmic reticulum. No detergent-insoluble enteropeptidase was detected. Pulse-labeled MDCK cells expressing BEK also did not contain detergent-insoluble enteropeptidase when chased at 20 °C for 1-5 h (data not shown). The results of these pulse-chase experiments suggest that intracellular association of enteropeptidase with rafts either does not occur or is extremely transient.

Association of certain membrane proteins with rafts may depend on clustering, and patching with antibodies is reported to allow increased recovery of placental alkaline phosphatase in detergent-resistant membrane domains (38). To determine whether patching could force enteropeptidase to associate with rafts, transfected BHK cells were incubated with anti-Lv and anti-rabbit immunoglobulin either before or after fixation for immunofluorescence microscopy (Fig. 8). When cells were fixed prior to the addition of antibodies, enteropeptidase was diffusely distributed on the cell surface with a fine punctate pattern (Fig. 8A). Fixation with acetic acid:ethanol permeabilizes the cells, so that intracellular enteropeptidase in the endoplasmic reticulum was also seen. This method was selected because a weak immunofluorescence signal was obtained with anti-Lv after fixation with 4% paraformaldehyde, which does not permeabilize cells. However, cell-surface staining is clearly distinguished by focusing through the cell, and the typical surface immunofluorescence pattern can be seen over the nucleus where the endoplasmic reticulum does not interfere. A similar fine punctate surface pattern was seen for caveolin (Fig. 8C). Preincuation of cells with anti-caveolin and anti-rabbit immunoglobulin gave no signal, confirming the integrity of the cells prior to permeabilization and the low background immunofluorescence of the method (Fig. 8D). Preincubation of cells with anti-Lv and anti-rabbit immunoglobulin resulted in redistribution of enteropeptidase into large surface patches (Fig. 8B). Despite patching with anti-Lv, enteropeptidase still was not recovered in detergent-resistant low density membrane fractions after treatment of cells with Triton X-100 at 4 °C (Fig. 9).


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 8.   Antibody-induced patching of enteropeptidase. Cells expressing full-length enteropeptidase (BEK) were fixed on ice and subsequently incubated with Cy3-conjugated goat anti-rabbit IgG and rabbit antibody to either enteropeptidase (A) or caveolin (C). Under these conditions, both antigens display a diffuse, finely punctate immunofluorescence pattern. Alternatively, cells were first incubated with Cy3-conjugated goat anti-rabbit IgG and antibody to either enteropeptidase (B) or caveolin (D), followed by fixation. Under these conditions, anti-caveolin does not have access to caveolin on the inner leaflet of the plasma membrane and there is only background immunofluorescence (D); anti-enteropeptidase causes the accumulation of enteropeptidase in large surface patches. Photographs were taken focusing on the apex of the cells to emphasize the pattern visible on the plasma membrane.


View larger version (59K):
[in this window]
[in a new window]
 
Fig. 9.   Effect of antibody-induced cross-linking on the association of enteropeptidase with detergent-resistant rafts. BHK cells expressing enteropeptidase (BEK) were incubated at 12 °C without (-Abs) or with (+Abs) rabbit anti-Lv and goat anti-rabbit IgG antibodies. Cells were extracted on ice with MES buffer, pH 6.5, containing 1% Triton X-100 and subjected to sucrose gradient centrifugation. Fractions were analyzed for enteropeptidase and caveolin (Cav) by SDS-PAGE and Western blotting as described under "Experimental Procedures."


    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Enteropeptidase is a type II integral membrane protein that is found in the apical microvilli of enterocytes in the duodenum and proximal jejunum (5). As shown by immunofluorescence microscopy (Fig. 3) and by selective cell-surface biotinylation (Fig. 4), the signals that specify its apical localization in enterocytes are functional in MDCK cells, a well characterized model system for the study of protein sorting in which most apical proteins are delivered directly to the apical cell surface (22, 29). The correct localization of enteropeptidase and other apical membrane proteins may be critical to their biological function, but the mechanisms of apical protein targeting are not well characterized. Whereas basolateral targeting often depends on compact structural motifs exposed in the cytoplasmic domains of transmembrane proteins, apical targeting instead appears to depend on any of several distributed features of other domains. These may include characteristics of the transmembrane domain (17), the presence of a glycosylphosphatidylinositol membrane anchor (18, 19), extracellular N-glycans (14, 15), or an O-glycosylated juxtamembrane segment (16).

In enteropeptidase at least two such apical sorting determinants appear to coexist, N-glycans and an O-glycosylated segment near the amino-terminal transmembrane domain. Bovine enteropeptidase has 19 potential N-linked glycosylation sites, three of which are in the carboxyl-terminal light chain (7). Many of these sites are utilized, as indicated by the large shift in apparent mass upon digestion with PNGase (Fig. 1). Unfortunately, inhibition of N-glycosylation with tunicamycin caused the intracellular degradation of full-length enteropeptidase (BEK) so that the role of N-glycans in targeting of the native protein could not be evaluated. However, the enteropeptidase light chain (L-BEK) was secreted apically and inhibition of N-glycosylation randomized its sorting (Fig. 5). Thus, N-glycans are required for apical sorting of the enteropeptidase light chain, as observed for several other secreted and membrane-bound glycoproteins (13).

A second sorting determinant is present near the amino terminus of the enteropeptidase heavy chain, and like the N-glycosylated light chain, it can direct the apical targeting of secreted variants of enteropeptidase. Replacement of the endogenous transmembrane domain with a cleavable signal peptide (dSA-BEK) and additional deletion of the light chain (dSAL-BEK) did not prevent apical targeting, but removal of residues 48-197 (HL-BEK) caused secretion from both apical and basolateral surfaces (Fig. 4). This segment is O-glycosylated (Fig. 1B), probably within a mucin-like domain between residues 166 and 192, and it also contains three potential N-glycosylation sites. Whether these oligosaccharides contribute to the apical targeting function of this segment has not been determined.

Other O-glycosylated proteins may be targeted apically independent of N-glycosylation. For example, the apical sorting of a neurotrophin receptor (p75NTR), a type I membrane protein, depends on an O-glycosylated juxtamembrane segment that remains functional in the absence of N-glycosylation and does not require membrane association for targeting (16). The O-glycans of p75NTR have not been proved to play a direct role in sorting, and it remains possible that other structural features constitute the apical sorting determinants. However, these results suggest that O-glycans as well as N-glycans may support apical targeting. Cells that are unable to complete complex-type oligosaccharides appear to target apical glycoproteins correctly (39, 40), suggesting that the mannose-rich core regions of N-glycans may comprise a sorting signal. Because mannose does not commonly occur in O-glycans, functional targeting motifs within N-linked and O-linked oligosaccharides could differ structurally and be recognized by distinct lectin-like components of the sorting pathway, as suggested by Scheiffele and colleagues (14). For example, VIP36 is an N-acetylgalactosamine-binding lectin of exocytic vesicles that might mediate targeting by O-glycans (41), and similar mannose-binding lectins might mediate targeting by N-glycans.

The heavy chain of enteropeptidase appears to contain a third functionally defined signal that can inhibit apical targeting in certain contexts. Addition of most of the heavy chain to the light chain caused the delivery of construct HL-BEK to both apical and basolateral surfaces, suggesting that the heavy chain inhibits apical targeting directed by the light chain (Fig. 4). In contrast, construct dSAL-BEK was secreted apically, indicating that the targeting function of the juxtamembrane region was not inhibited by inclusion of the remainder of the heavy chain. Both chains are extensively N-glycosylated, and the mechanism by which a portion of the glycosylated heavy chain could inhibit the N-glycan-dependent targeting of the light chain is unknown. Additional targeting determinants may be present in enteropeptidase. In particular, our studies do not exclude an independent or supplementary targeting function of the enteropeptidase transmembrane domain.

Although they may employ distinct targeting signals, many apically sorted membrane proteins associate with glycosphingolipid and cholesterol-rich rafts (20). Rafts are resistant to dissolution by Triton X-100 at 4 °C, and raft proteins are operationally defined by their recovery in low density Triton X-100-insoluble membrane domains that are isolated by differential centrifugation. For example, apical targeting can be mediated by the transmembrane domain of influenza virus hemagglutinin or the glycosylphosphatidylinositol anchor of alkaline phosphatase, and these proteins are recovered in detergent-resistant rafts (17, 42, 43). Several apical N-glycosylated intestinal hydrolases with type I or type II transmembrane topology also are found in rafts (35).

Enteropeptidase does not fit this pattern because full-length membrane-bound BEK was solubilized completely by extraction of cells with Triton X-100 (Fig. 6); transient intracellular association with detergent-resistant rafts was not evident, with or without blockage of delivery to the plasma membrane by incubation of cells at 20 °C (Fig. 6, B and C). Enteropeptidase also was not recovered in low density membrane fractions upon sucrose density gradient centrifugation (Fig. 7). The association of glycosylphosphatidylinositol-linked placental alkaline phosphatase with rafts reportedly was enhanced by patching with antibody prior to detergent extraction so that raft association was stable even at 30 °C, a temperature at which alkaline phosphatase otherwise is completely soluble in Triton X-100 (38). In the case of enteropeptidase this maneuver caused it to cluster into large membrane aggregates (Fig. 8) but did not prevent solubilization by Triton X-100 at 4 °C (Fig. 9). Thus, apical targeting of enteropeptidase does not appear to depend on detergent-resistant association with rafts.

Certain other apical proteins also do not appear to associate tightly with rafts. Intestinal maltase-glucoamylase shares with enteropeptidase the structural features of type II transmembrane topology, extensive N-linked glycosylation, and a juxtamembrane mucin-like domain that may be O-glycosylated (44); both proteins are sorted apically and are solubilized by Triton X-100 (35). Lactase-phlorizin hydrolase is an extensively N-glycosylated type I transmembrane protein that also is sorted to the apical surface of enterocytes and is solubilized by Triton X-100 (35). Based on these examples, efficient apical targeting of N-glycosylated transmembrane proteins can occur with or without detergent-resistant raft association.

Secreted glycoproteins also are not incorporated directly into rafts but nevertheless can be targeted apically, again raising the question of whether some apical targeting pathways may be independent of rafts. However, transient raft association within the cell could be sufficient for delivery to the apical plasma membrane, after which secreted or transmembrane proteins could dissociate and diffuse away from the rafts that brought them there. Apical secretory proteins could bind to rafts indirectly, perhaps through interaction of their N-glycans with lectin-like sorting receptors (14). Similarly, apical transmembrane glycoproteins could interact with rafts directly through transmembrane domain-lipid interactions or indirectly through protein-protein interactions that involve intrinsic raft proteins, and these interactions may not be stable after disruption of the supporting lipid bilayer with detergents (38, 45). If such a model were correct, then the ability to detect raft association could be sensitive to the assay conditions. For example, the glycoprotein clusterin is secreted apically from MDCK cells and could be solubilized completely by extraction of cells with Triton X-100 at pH 7.5 (46); however, extraction at pH 6.2 was reported to allow detection of CHAPS-insoluble clusterin, suggesting a weak association with rafts (45). Depletion of cellular cholesterol also caused mis-sorting of clusterin, and this result indirectly supports a function of cholesterol-rich rafts in its apical targeting (45). At the present time we have not recovered enteropeptidase in low density raft membranes at pH 6.5, even after patching enteropeptidase on the cell surface with antibodies. Therefore, if rafts participate in targeting enteropeptidase, the mode of involvement remains to be defined.

    ACKNOWLEDGEMENT

We thank Dr. Linda Pike (Washington University) for assistance in the preparation of detergent-insoluble rafts.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grant DK50053.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Howard Hughes Medical Institute, Washington University School of Medicine, 660 South Euclid Ave., Box 8022, St. Louis, MO 63110. Tel.: 314-362-9029; Fax: 314-454-3012; E-mail: esadler{at}im.wustl.edu.

The abbreviations used are: MDCK, Madin-Darby canine kidney; BEK, recombinant bovine proenteropeptidase; dSA-BEK, mutant proenteropeptidase lacking the amino-terminal signal anchor domain; dSAdL-BEK, mutant proenteropeptidase lacking the signal anchor, mucin-like, and light chain domains; HL-BEK, mutant proenteropeptidase lacking the amino-terminal signal anchor and mucin-like domains; L-BEK, mutant proenteropeptidase containing the light chain and 17 carboxyl-terminal residues of the heavy chain; NHS-SS-biotin, sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithiopropionate; PAGE, polyacrylamide gel electrophoresis; DMEM, Dulbecco's modified Eagle's medium; MOPS, 4-morpholinepropanesulfonic acid; PMSF, phenylmethylsulfonyl fluoride; PBS, phosphate-buffered saline; BHK, baby hamster kidney; PNGase, peptide N-glycosidase; endo H, endoglycosidase H; MES, 4-morpholineethanesulfonic acid; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; BSA, bovine serum albumin.

2 D. Lu, X. Zheng, and J. E. Sadler, manuscript in preparation.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Hadorn, B., Tarlow, M. J., Lloyd, J. K., and Wolff, O. H. (1969) Lancet i, 812-813
  2. Haworth, J. C., Gourley, B., Hadorn, B., and Sumida, C. (1971) J. Pediatr. 78, 481-490[Medline] [Order article via Infotrieve]
  3. Hammond, J. B., and Mann, N. S. (1977) Dig. Dis. 22, 182-188
  4. Grant, D. (1986) Int. J. Pancreatol. 1, 167-183[Medline] [Order article via Infotrieve]
  5. Lu, D., and Sadler, J. E. (1998) in Handbook of Proteolytic Enzymes (Barrett, A. J., Rawlings, N. D., and Woessner, J. F., Jr., eds), pp. 50-54, Academic Press Ltd., London
  6. LaVallie, E. R., Rehemtulla, A., Racie, L. A., DiBlasio, E. A., Ferenz, C., Grant, K. L., Light, A., and McCoy, J. M. (1993) J. Biol. Chem. 268, 23311-23317[Abstract/Free Full Text]
  7. Kitamoto, Y., Yuan, X., Wu, Q., McCourt, D. W., and Sadler, J. E. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 7588-7592[Abstract]
  8. Matsushima, M., Ichinose, M., Yahagi, N., Kakei, N., Tsukada, S., Miki, K., Kurokawa, K., Tashiro, K., Shiokawa, K., Shinomiya, K., Umeyama, H., Inoue, H., Takahashi, T., and Takahashi, K. (1994) J. Biol. Chem. 269, 19976-19982[Abstract/Free Full Text]
  9. Kitamoto, Y., Veile, R. A., Donis-Keller, H., and Sadler, J. E. (1995) Biochemistry 34, 4562-4568[Medline] [Order article via Infotrieve]
  10. Yuan, X., Zheng, X. L., Lu, D. S., Rubin, D. C., Pung, C. Y. M., and Sadler, J. E. (1998) Am. J. Physiol. 37, G342-G349
  11. Yahagi, N., Ichinose, M., Matsushima, M., Matsubara, Y., Miki, K., Kurokawa, K., Fukamachi, H., Tashiro, K., Shiokawa, K., Kageyama, T., Takahashi, T., Inoue, H., and Takahashi, K. (1996) Biochem. Biophys. Res. Commun. 219, 806-812[CrossRef][Medline] [Order article via Infotrieve]
  12. Lu, D., Yuan, X., Zheng, X., and Sadler, J. E. (1997) J. Biol. Chem. 272, 31293-31300[Abstract/Free Full Text]
  13. Keller, P., and Simons, K. (1997) J. Cell Sci. 110, 3001-3009[Abstract/Free Full Text]
  14. Scheiffele, P., Peranen, J., and Simons, K. (1995) Nature 378, 96-98[CrossRef][Medline] [Order article via Infotrieve]
  15. Gut, A., Kappeler, F., Hyka, N., Balda, M. S., Hauri, H. P., and Matter, K. (1998) EMBO J. 17, 1919-1929[Free Full Text]
  16. Yeaman, C., Le Gall, A. H., Baldwin, A. N., Monlauzeur, L., Le Bivic, A., and Rodriguez-Boulan, E. (1997) J. Cell Biol. 139, 929-940[Abstract/Free Full Text]
  17. Scheiffele, P., Roth, M. G., and Simons, K. (1997) EMBO J. 16, 5501-5508[Abstract/Free Full Text]
  18. Brown, D. A., Crise, B., and Rose, J. K. (1989) Science 245, 1499-1501[Medline] [Order article via Infotrieve]
  19. Lisanti, M. P., Caras, I. W., Davitz, M. A., and Rodriguez-Boulan, E. (1989) J. Cell Biol. 109, 2145-2156[Abstract]
  20. Simons, K., and Ikonen, E. (1997) Nature 387, 569-572[CrossRef][Medline] [Order article via Infotrieve]
  21. Alonso, M. A., Fan, L., and Alarcon, B. (1997) J. Biol. Chem. 272, 30748-30752[Abstract/Free Full Text]
  22. Matter, K., and Mellman, I. (1994) Curr. Opin. Cell Biol. 6, 545-554[Medline] [Order article via Infotrieve]
  23. Palmiter, R. D., Behringer, R. R., Quaife, C. J., Maxwell, F., Maxwell, I. H., and Brinster, R. L. (1987) Cell 50, 435-443[Medline] [Order article via Infotrieve]
  24. Harlow, E., and Lane, D. (1988) Antibodies: A Laboratory Manual, Vol. 1, pp. 92-135, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  25. Beau, I., Misrahi, M., Gross, B., Vannier, B., Loosfelt, H., Hai, M. T., Pichon, C., and Milgrom, E. (1997) J. Biol. Chem. 272, 5241-5248[Abstract/Free Full Text]
  26. Marzolo, M. P., Bull, P., and Gonzalez, A. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1834-1839[Abstract/Free Full Text]
  27. Brown, D. A., and Rose, J. K. (1992) Cell 68, 533-544[Medline] [Order article via Infotrieve]
  28. Pike, L. J., and Casey, L. (1996) J. Biol. Chem. 271, 26453-26456[Abstract/Free Full Text]
  29. Wandinger-Ness, A., Bennett, M. K., Antony, C., and Simons, K. (1990) J. Cell Biol. 111, 987-1000[Abstract]
  30. Parczyk, K., Haase, W., and Kondor-Koch, C. (1989) J. Biol. Chem. 264, 16837-16846[Abstract/Free Full Text]
  31. Rindler, M. J., Ivanov, I. E., and Sabatini, D. D. (1987) J. Cell Biol. 104, 231-241[Abstract]
  32. Low, S. H., Wong, S. H., Tang, B. L., Tan, P., Subramaniam, V. N., and Hong, W. (1991) J. Biol. Chem. 266, 17729-17732[Abstract/Free Full Text]
  33. Low, S. H., Tang, B. L., Wong, S. H., and Hong, W. (1992) J. Cell Biol. 118, 51-62[Abstract]
  34. Skibbens, J. E., Roth, M. G., and Matlin, K. S. (1989) J. Cell Biol. 108, 821-832[Abstract]
  35. Danielsen, E. M. (1995) Biochemistry 34, 1596-1605[Medline] [Order article via Infotrieve]
  36. Matlin, K. S., and Simons, K. (1983) Cell 34, 233-243[Medline] [Order article via Infotrieve]
  37. Griffiths, G., Pfeiffer, S., Simons, K., and Matlin, K. (1985) J. Cell Biol. 101, 949-964[Abstract]
  38. Harder, T., Scheiffele, P., Verkade, P., and Simons, K. (1998) J. Cell Biol. 141, 929-942[Abstract/Free Full Text]
  39. Parczyk, K., and Koch-Brandt, C. (1991) FEBS Lett. 278, 267-270[CrossRef][Medline] [Order article via Infotrieve]
  40. Wagner, M., Morgans, C., and Koch-Brandt, C. (1995) Eur. J. Cell Biol. 67, 84-88[Medline] [Order article via Infotrieve]
  41. Fiedler, K., and Simons, K. (1996) J. Cell Sci. 109, 271-276[Abstract/Free Full Text]
  42. Hanada, K., Nishijima, M., Akamatsu, Y., and Pagano, R. E. (1995) J. Biol. Chem. 270, 6254-6260[Abstract/Free Full Text]
  43. Arreaza, G., and Brown, D. A. (1995) J. Biol. Chem. 270, 23641-23647[Abstract/Free Full Text]
  44. Nichols, B. L., Eldering, J., Avery, S., Hahn, D., Quaroni, A., and Sterchi, E. (1998) J. Biol. Chem. 273, 3076-3081[Abstract/Free Full Text]
  45. Keller, P., and Simons, K. (1998) J. Cell Biol. 140, 1357-1367[Abstract/Free Full Text]
  46. Graichen, R., Losch, A., Appel, D., and Koch-Brandt, C. (1996) J. Biol. Chem. 271, 15854-15857[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.